Document is current
Any future updates will be listed below
-
Authors
Haqaish, Wesal Salem Al
Obeidat, Hayel
Patel, Prisha
Walker, Stuart
- License Information
-
More Information
Article History
First Online: 15 December 2016
Compliance with Ethical Standards
:
: This independent research study was conducted by CIRS as part of its ongoing initiatives to understand pharmaceutical development and regulatory activities in emerging markets. No funding was received for the development of this manuscript.
: Wesal Salem Al Haqaish is the Head, Drug Registration, JFDA. Hayel Obeidat is the Director General, JFDA. Prisha Patel is employed by, and Stuart Walker is the founder of, CIRS, London, UK, which conducted the research described in this report.
